These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7679601)

  • 1. Adenocarcinoma of the testis--lack of response to conventional chemotherapy.
    Crellin RP; Cornbleet MA; McIntyre MA
    Br J Urol; 1993 Jan; 71(1):98-9. PubMed ID: 7679601
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis.
    Johnson E
    J Clin Oncol; 1991 Jun; 9(6):1092-4. PubMed ID: 1709684
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 4. [Randomized phase III study on nonseminomatous testicular tumor].
    Rexer H
    Urologe A; 2004 Nov; 43(11):1432-3. PubMed ID: 15526083
    [No Abstract]   [Full Text] [Related]  

  • 5. Stage I testicular cancer management and necessity for surgical expertise.
    Sheinfeld J; Motzer RJ
    J Clin Oncol; 2008 Jun; 26(18):2934-6. PubMed ID: 18458042
    [No Abstract]   [Full Text] [Related]  

  • 6. Low dose bleomycin with etoposide and cisplatin for metastatic testicular teratoma.
    Coleman RE; Whillis D; Howard GC; Taylor RE; Cornbleet MA
    Br J Urol; 1991 Sep; 68(3):296-300. PubMed ID: 1717098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of high risk patients with advanced testis cancer: National Cancer Institute approach.
    Ozols RF; Ihde DC; Linehan WM; Young RC
    Semin Oncol; 1988 Aug; 15(4):335-8. PubMed ID: 2457255
    [No Abstract]   [Full Text] [Related]  

  • 8. Defining new standards for adjuvant therapy of testis cancer.
    Nichols CR; Gonin R; Foster R
    J Clin Oncol; 1995 Nov; 13(11):2681-3. PubMed ID: 7595724
    [No Abstract]   [Full Text] [Related]  

  • 9. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metastatic testicular tumours with bleomycin, etoposide, cisplatin and vincristine.
    Price BA; Peters NH
    Eur J Cancer; 1992; 28(2-3):615. PubMed ID: 1375487
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.
    van den Hengel LG; van Steijn-van Tol AQ; Bertina RM; Versteeg HH; Osanto S
    Thromb Res; 2013 Feb; 131(2):187-9. PubMed ID: 23260444
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of "good risk" metastatic testicular cancer.
    Garrow GC; Johnson DH
    Semin Oncol; 1992 Apr; 19(2):159-65. PubMed ID: 1372758
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of good-risk disseminated non-seminomatous germ cell tumours: the less bleomycin, the more cisplatin?
    Culine S; Mahjoubi M; Philippot I; Droz JP
    Eur J Cancer; 1991; 27(12):1715. PubMed ID: 1723608
    [No Abstract]   [Full Text] [Related]  

  • 15. Short-course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumours.
    Oliver RT; Dhaliwal HS; Hope-Stone HF; Blandy JP
    Br J Urol; 1988 Jan; 61(1):53-8. PubMed ID: 2449257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
    Bokemeyer C
    J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of testicular cancer in which complete response was achieved with chemotherapy including cisplatin, etoposide and bleomycin, and salvage surgery].
    Uekado Y; Matsumoto M; Inagaki T; Shintani Y
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):543-6. PubMed ID: 7510465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New testis tumor study AH 09/03/XX--darbepoetin activated].
    Rexer H
    Urologe A; 2004 May; 43(5):586. PubMed ID: 15083275
    [No Abstract]   [Full Text] [Related]  

  • 20. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
    Peckham MJ; Horwich A; Blackmore C; Hendry WF
    Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.